Boronic acid derivatives
Cayman Chemical 19 SHETE Fatty Acids and Deriv
Potent vasodilator of renal preglomerular vessels; 70% of the metabolite composition of arachidonic acid by CYP2E1; stimulates both renal sodium-potassium ATPase and volume absorption in the rabbit proximal straight tubule
Cambridge Isotope Laboratories Modified JIS Dioxin Furan Calibration Solution (CS6H) 0 2 mL
Modified JIS Dioxin Furan Calibration Solution (CS6H) 0 2 mL
Cayman Chemical CAY10591 Fatty Acids and Deriv
An activator of SIRT1 that decreases TNF-α levels from 325 pg/ml (control) to 104 and 53 pg/ml at 20 and 60 µM, respectively; exhibits a significant dose-dependent effect on fat mobilization in differentiated adipocytes
Chemscene ChemScene | (4-Bromonaphthalen-1-yl)boronic acid | 10G | CS-0041436 | 0.98 | 145965-14-6| MFCD08701764 | 250.89
ChemScene | (4-Bromonaphthalen-1-yl)boronic acid | 10G | CS-0041436 | 0.98 | 145965-14-6| MFCD08701764 | 250.89
Cambridge Isotope Laboratories Dioxin Furan Food/Feed/QQQ Calibration Standard (CS8) 0 25 mL
Dioxin Furan Food/Feed/QQQ Calibration Standard (CS8) 0 25 mL
Cayman Chemical CAY10499 Fatty Acids and Deriv
A non-selective lipase inhibitor (IC50s = 144, 90, and 14 nM for human recombinant MAGL, HSL, and FAAH, respectively); inhibits ATGL, DAGLa, ABHD6, and CES1 at 5 mM; inhibits the growth of MCF-7, MDA-MB-231, COV318, and OVCAR-3 cancer cells (IC50s = 4.2, 46, 106.7, and 79.8 µM, respectively); reduces FRUC diet- and AIN-93M diet-induced increases in cytosolic lipase activity in rats
Cambridge Isotope Laboratories Bromodioxin/Furan Calibration Standard Solution (CS4) 0 2 mL
Bromodioxin/Furan Calibration Standard Solution (CS4) 0 2 mL
Medchemexpress LLC Cyclopropylboronic acid | 411235-57-9 | 99.2% | C3H7BO2 | 1 KG
Cyclopropylboronic acid is an intermediate used to synthesize EGFR kinase inhibitor (Compound 25). Compound 25 has antiproliferative effects on EGFR mutant (EGFR Δ19del/T790M/C797S) cells and can be used in lung cancer research.
- Intermediate used to synthesize EGFR kinase inhibitor (Compound 25)
- Exhibits antiproliferative effects on EGFR mutant (EGFR Δ19del/T790M/C797S) cells
- Applicable in lung cancer research
- Inhibits Ba/F3 triple-mutant suspension cells with an IC50 of 642 nM
- Appearance as an off-white to yellow solid
- Soluble in DMSO at concentrations of 100 mg/mL or greater
- Powder stable for 3 years at -20°C
- In solvent, stable for 6 months at -80°C or 1 month at -20°C
Advanced Chemblocks Inc 2,3-DIHYDROBENZOFURAN-4-1G
2,3-DIHYDROBENZOFURAN-4-OL, 144822-82-2, MFCD08703214